A TNF-regulated recombinatorial macrophage immune receptor implicated in granuloma formation in tuberculosis

PLoS Pathogens

Volumn 7, Issue 11, 2011, Pages

  Beham, Alexander W ^a   Puellmann, Kerstin ^b   Laird, Rebecca ^a   Fuchs, Tina ^c   Streich, Roswita ^a   Breysach, Caroline ^a   Raddatz, Dirk ^a   Oniga, Septimia ^c   Peccerella, Teresa ^c   Findeisen, Peter ^c   Kzhyshkowska, Julia ^c,d   Gratchev, Alexei ^c,d   Schweyer, Stefan ^a   Saunders, Bernadette ^e   Wessels, Johannes T ^a   Möbius, Wiebke ^f   Keane, Joseph ^g   Becker, Heinz ^a   Ganser, Arnold ^b   Neumaier, Michael ^c   Kaminski, Wolfgang E ^c   more..

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

^e CENTENARY INSTITUTE   (Australia)

^f MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^g TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; RECEPTOR ANTIBODY; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TUMOR NECROSIS FACTOR; CCL2 PROTEIN, MOUSE; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHIMERA; GIEMSA STAIN; GRANULOMA; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG TUBERCULOSIS; MACROPHAGE; MONOCYTE; MOUSE; MYCOBACTERIUM; NONHUMAN; T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; IMMUNOLOGY; MICROBIOLOGY; PATHOLOGY; VDJ RECOMBINATION;

CORYNEBACTERINEAE;

ANIMALS; CHEMOKINE CCL2; GRANULOMA; HUMANS; MACROPHAGES; MICE; MONOCYTES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, TUMOR NECROSIS FACTOR; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA; V(D)J RECOMBINATION;

EID: 81755177741     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002375     Document Type: Article

References (32)

1. Janeway CA Jr, Medzhitov R, (2002) Innate immune recognition. Annu Rev Immunol 20: 197-216.
2. Glaziou P, Floyd K, Raviglione M, (2009) Global burden and epidemiology of tuberculosis. Clin Chest Med 30: 621-636, vii.
3. Miller EA, Ernst JD, (2008) Illuminating the black box of TNF action in tuberculous granulomas. Immunity 29: 175-177.
4. Kaufmann SH, (2006) Tuberculosis: back on the immunologists' agenda. Immunity 24: 351-357.
5. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, et al. (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345: 1098-1104.
6. Izzo AA, North RJ, (1992) Evidence for an alpha/beta T cell-independent mechanism of resistance to mycobacteria. Bacillus-Calmette-Guerin causes progressive infection in severe combined immunodeficient mice, but not in nude mice or in mice depleted of CD4+ and CD8+ T cells. J Exp Med 176: 581-586.
7. Saunders BM, Briscoe H, Britton WJ, (2004) T cell-derived tumour necrosis factor is essential, but not sufficient, for protection against Mycobacterium tuberculosis infection. Clin Exp Immunol 137: 279-287.
8. Saunders BM, Tran S, Ruuls S, Sedgwick JD, Briscoe H, et al. (2005) Transmembrane TNF is sufficient to initiate cell migration and granuloma formation and provide acute, but not long-term, control of Mycobacterium tuberculosis infection. J Immunol 174: 4852-4859.
9. Puellmann K, Kaminski WE, Vogel M, Nebe TC, Schröder J, et al. (2006) From the cover: A variable immunoreceptor in a subpopulation of human neutrophils. Proc Natl Acad Sci USA 103: 14441-14446.
10. Puellmann K, Beham AW, Kaminski WE, (2006) Cytokine storm and an anti-CD28 monoclonal antibody. N Engl J Med 355: 2592-2593; author reply 2593-2594.
11. Legrand F, Driss V, Woerly G, Loiseau S, Hermann E, et al. (2009) A functional gammadeltaTCR/CD3 complex distinct from gammadeltaT cells is expressed by human eosinophils. PLoS One 4: e5926.
12. Kzhyshkowska J, Gratchev A, Schmuttermaier C, Brundiers H, Krusell L, et al. (2008) Alternatively activated macrophages regulate extracellular levels of the hormone placental lactogen via receptor-mediated uptake and transcytosis. J Immunol 180: 3028-3037.
13. van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, et al. (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17: 2257-2317.
14. Genevee C, Diu A, Nierat J, Caignard A, Dietrich PY, et al. (1992) An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur J Immunol 22: 1261-1269.
15. Virchow R, (1856) Aus dem pathologisch-anatomischen Curse. Wien Med Wschr 51: 811-812.
16. Gardam MA, Keystone EC, Menzies R, Manners S, Skamene E, et al. (2003) Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 3: 148-155.
17. Wallis RS, (2008) Tumour necrosis factor antagonists: structure, function, and tuberculosis risks. Lancet Infect Dis 8: 601-611.
18. Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP, (2008) Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther 117: 244-279.
19. Wallis RS, Kyambadde P, Johnson JL, Horter L, Kittle R, et al. (2004) A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis. Aids 18: 257-264.
20. Ouchida R, Yamasaki S, Hikida M, Masuda K, Kawamura K, et al. (2008) A lysosomal protein negatively regulates surface T cell antigen receptor expression by promoting CD3zeta-chain degradation. Immunity 29: 33-43.
21. Gastman BR, Johnson DE, Whiteside TL, Rabinowich H, (1999) Caspase-mediated degradation of T-cell receptor zeta-chain. Cancer Res 59: 1422-1427.
22. Bean AG, Roach DR, Briscoe H, France MP, Korner H, et al. (1999) Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol 162: 3504-3511.
23. Bell JJ, Bhandoola A, (2008) The earliest thymic progenitors for T cells possess myeloid lineage potential. Nature 452: 764-767.
24. Sun JC, Beilke JN, Lanier LL, (2009) Adaptive immune features of natural killer cells. Nature 457: 557-561.
25. Wada H, Masuda K, Satoh R, Kakugawa K, Ikawa T, et al. (2008) Adult T-cell progenitors retain myeloid potential. Nature 452: 768-772.
26. Li J, Barreda DR, Zhang YA, Boshra H, Gelman AE, et al. (2006) B lymphocytes from early vertebrates have potent phagocytic and microbicidal abilities. Nat Immunol 7: 1116-1124.
27. Miller EA, Ernst JD, (2009) Anti-TNF immunotherapy and tuberculosis reactivation: another mechanism revealed. J Clin Invest 119: 1079-1082.
28. Kzhyshkowska J, Gratchev A, Martens JH, Pervushina O, Mamidi S, et al. (2004) Stabilin-1 localizes to endosomes and the trans-Golgi network in human macrophages and interacts with GGA adaptors. J Leukoc Biol 76: 1151-1161.
29. Kaminski WE, Lindahl P, Lin N, Broudy V, Crosby J, et al. (2001) Basis of hematopoietic defects in platelet-derived growth factor (PDGF)-B and PDGF beta-receptor null mice. Blood 97: 1990-1998.
30. (2008) WMA Declaration of Helsinki- Ethical Principles for Medical Research Involving Human Subjects www.wma.net/en/30publications/10policies/b3/index.html.
31. Findeisen P, Neumaier M, (2009) Mass spectrometry-based clinical proteomics profiling: current status and future directions. Expert Rev Proteomics 6: 457-459.
32. Bienvenut WV, Deon C, Pasquarello C, Campbell JM, Sanchez JC, et al. (2002) Matrix-assisted laser desorption/ionization-tandem mass spectrometry with high resolution and sensitivity for identification and characterization of proteins. Proteomics 2: 868-876.